Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B Journal Articles Refereed uri icon

Overview

Published in

  • Gut

Time

Date/time value

  • 2017

Identity

Digital Object Identifier (DOI)

  • 10.1136/gutjnl-2015-309300

Additional Document Info

Parent Title

  • GUT

Volume

  • 66

Issue

  • 11

Publisher

  • British Medical Journal Publishing Group